China Microfluidics Market Size & Outlook, 2023-2030

The microfluidics market in China is expected to reach a projected revenue of US$ 4,436.3 million by 2030. A compound annual growth rate of 17.5% is expected of China microfluidics market from 2024 to 2030.
Revenue, 2023 (US$M)
$1,437.7
Forecast, 2030 (US$M)
$4,436.3
CAGR, 2024 - 2030
17.5%
Report Coverage
China

China microfluidics market highlights

  • The China microfluidics market generated a revenue of USD 1,437.7 million in 2023 and is expected to reach USD 4,436.3 million by 2030.
  • The China market is expected to grow at a CAGR of 17.5% from 2024 to 2030.
  • In terms of segment, medical was the largest revenue generating technology in 2023.
  • Medical is the most lucrative technology segment registering the fastest growth during the forecast period.


Microfluidics market data book summary

Market revenue in 2023USD 1,437.7 million
Market revenue in 2030USD 4,436.3 million
Growth rate17.5% (CAGR from 2023 to 2030)
Largest segmentMedical
Fastest growing segmentMedical
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationMedical, Non-Medical
Key market players worldwideIllumina Inc, Roche Holding AG ADR, PerkinElmer, Agilent Technologies Inc, Bio-Rad Laboratories Inc, Danaher Corp, Abbott Laboratories, Thermo Fisher Scientific Inc, Standard BioTools Inc


Other key industry trends

  • In terms of revenue, China accounted for 4.5% of the global microfluidics market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, Japan microfluidics market is projected to lead the regional market in terms of revenue in 2030.
  • China is the fastest growing regional market in Asia Pacific and is projected to reach USD 4,436.3 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Microfluidics Market Companies

Name Profile # Employees HQ Website

China microfluidics market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to microfluidics market will help companies and investors design strategic landscapes.


Medical was the largest segment with a revenue share of 84.11% in 2023. Horizon Databook has segmented the China microfluidics market based on medical, non-medical covering the revenue growth of each sub-segment from 2018 to 2030.


The market for medical diagnostics, high throughput screening, and bio-sensing is growing in China owing to increasing government support for advanced infrastructure and strong intellectual property right ownership.

The other driving factor is the ever-increasing need for healthcare services, which increased the demand for medical diagnostics. Being a developing country, China has huge potential for microfluidics market. Improved economic conditions also drive investments in the field of diagnostics.

Since 2005, China has the highest number of research papers published with microfluidics as a keyword. Moreover, rapidly growing diagnostics market and collaborations or acquisitions of international companies with domestic players is expected to boost the market growth.

Reasons to subscribe to China microfluidics market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of China microfluidics market databook

  • Our clientele includes a mix of microfluidics market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the China microfluidics market , including forecasts for subscribers. This country databook contains high-level insights into China microfluidics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

China microfluidics market size, by technology, 2018-2030 (US$M)

China Microfluidics Market Outlook Share, 2023 & 2030 (US$M)

China microfluidics market size, by technology, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more